Atyr Pharma Inc (NASDAQ:ATYR) has a beta value of 0.99 and has seen 1.15 million shares traded in the recent trading session. The company, currently valued at $350.05M, closed the recent trade at $4.17 per share which meant it gained $0.38 on the day or 10.03% during that session. The ATYR stock price is -1.2% off its 52-week high price of $4.22 and 65.95% above the 52-week low of $1.42.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

Sporting 10.03% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ATYR stock price touched $4.17 or saw a fall of -0.97%. Year-to-date, Atyr Pharma Inc shares have moved 15.20%, while the 5-day performance has seen it change 12.40%. Over the past 30 days, the shares of Atyr Pharma Inc (NASDAQ:ATYR) have changed 15.52%.

Atyr Pharma Inc (ATYR) estimates and forecasts

The company’s shares have gained 118.33% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -48.36%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 43.36% over the past 5 years. Earnings growth for 2025 is a modest 3.09% while over the next 5 years, the company’s earnings are expected to increase by 13.95%.

ATYR Dividends

Atyr Pharma Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders

Also the top two Mutual Funds that are holding company’s shares are Federated Hermes Kaufmann Fund and Federated Hermes Kaufmann Small Cap Fund. As of Oct 31, 2024, the former fund manager holds about 9.35% shares in the company for having 7.85 shares of worth $32.77 million while later fund manager owns 6.62 shares of worth $27.64 million as of Oct 31, 2024, which makes it owner of about 7.89% of company’s outstanding stock.